$ELAN
Elanco Animal Health Inc Stock $elan

$elan Overview Financials Valuation SEC Filings Company Website

2020 Q4 Form 10-K Financial Statement

#000173910421000004 Filed on March 01, 2021

Income Statement

Concept	2020 Q4	2019 Q4	2018 Q4
Revenue	$1.140B	$787.0M	$799.3M
YoY Change	44.82%	-1.54%	5.97%
Cost Of Revenue	$596.2M	$410.1M	$412.5M
YoY Change	45.38%	-0.58%	1.85%
Gross Profit	$543.5M	$376.9M	$386.8M
YoY Change	44.2%	-2.56%	10.74%
Gross Profit Margin	47.69%	47.89%	48.39%
Selling, General & Admin	$374.1M	$185.9M	$185.1M
YoY Change	101.24%	0.43%	-5.9%
% of Gross Profit	68.83%	49.32%	47.85%
Research & Development	$112.7M	$67.30M	$61.10M
YoY Change	67.46%	10.15%	-1.29%
% of Gross Profit	20.74%	17.86%	15.8%
Depreciation & Amortization	$222.2M	$83.40M	$73.70M
YoY Change	166.43%	13.16%	-15.38%
% of Gross Profit	40.88%	22.13%	19.05%
Operating Expenses	$486.8M	$253.2M	$246.2M
YoY Change	92.26%	2.84%	-4.87%
Operating Profit	$56.70M	$123.7M	$140.6M
YoY Change	-54.16%	-12.02%	55.36%
Interest Expense	$60.40M	$18.70M	$21.00M
YoY Change	222.99%	-10.95%
% of Operating Profit	106.53%	15.12%	14.94%
Other Income/Expense, Net	$16.60M	-$6.300M	-$25.70M
YoY Change	-363.49%	-75.49%	12750.0%
Pretax Income	-$318.1M	-$4.300M	-$2.200M
YoY Change	7297.67%	95.45%	-98.58%
Income Tax	$4.700M	$5.200M	-$18.60M
% Of Pretax Income
Net Earnings	-$322.8M	-$9.500M	$16.40M
YoY Change	3297.89%	-157.93%	-110.15%
Net Earnings / Revenue	-28.32%	-1.21%	2.05%
Basic Earnings Per Share
Diluted Earnings Per Share	-$664.1K	-$25.48K	$44.86K
COMMON SHARES
Basic Shares Outstanding	471.9M shares	373.0M shares	365.6M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2020 Q4	2019 Q4	2018 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$495.0M	$334.0M	$475.0M
YoY Change	48.2%	-29.68%	47.06%
Cash & Equivalents	$495.0M	$334.0M	$474.8M
Short-Term Investments
Other Short-Term Assets	$267.0M	$98.00M	$317.0M
YoY Change	172.45%	-69.09%	133.09%
Inventory	$1.578B	$1.051B	$1.004B
Prepaid Expenses
Receivables	$872.0M	$816.9M	$651.8M
Other Receivables	$205.0M	$73.00M	$57.60M
Total Short-Term Assets	$3.417B	$2.373B	$2.505B
YoY Change	43.99%	-5.26%	17.95%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.316B	$955.3M	$922.4M
YoY Change	37.76%	3.57%	0.23%
Goodwill	$6.225B	$2.990B	$3.000B
YoY Change	108.22%	-0.35%	1.04%
Intangibles	$6.387B	$2.483B	$2.505B
YoY Change	157.25%	-0.88%	-6.29%
Long-Term Investments	$24.00M	$18.80M	$15.30M
YoY Change	27.66%	22.88%	27.5%
Other Assets	$348.0M	$185.0M	$66.60M
YoY Change	88.11%	177.78%	-72.48%
Total Long-Term Assets	$14.28B	$6.613B	$6.452B
YoY Change	115.89%	2.49%	-5.35%
TOTAL ASSETS
Total Short-Term Assets	$3.417B	$2.373B	$2.505B
Total Long-Term Assets	$14.28B	$6.613B	$6.452B
Total Assets	$17.69B	$8.986B	$8.957B
YoY Change	96.9%	0.32%	0.18%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$501.0M	$222.6M	$205.2M
YoY Change	125.07%	8.48%	0.69%
Accrued Expenses	$181.0M	$123.0M	$99.00M
YoY Change	47.15%	24.24%	11.24%
Deferred Revenue	$295.0M	$211.0M	$169.9M
YoY Change	39.81%	24.19%	2.66%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$555.0M	$24.50M	$29.00M
YoY Change	2165.31%	-15.52%
Total Short-Term Liabilities	$2.077B	$818.5M	$970.7M
YoY Change	153.76%	-15.68%	50.94%
LONG-TERM LIABILITIES
Long-Term Debt	$5.572B	$2.331B	$2.443B
YoY Change	139.09%	-4.62%
Other Long-Term Liabilities	$322.0M	$106.6M	$121.5M
YoY Change	202.06%	-12.26%	-3.57%
Total Long-Term Liabilities	$5.894B	$2.437B	$2.565B
YoY Change	141.84%	-4.98%	1935.56%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.077B	$818.5M	$970.7M
Total Long-Term Liabilities	$5.894B	$2.437B	$2.565B
Total Liabilities	$9.217B	$3.439B	$3.759B
YoY Change	168.02%	-8.52%	224.07%
SHAREHOLDERS EQUITY
Retained Earnings	-$477.0M	$84.30M	$16.40M
YoY Change	-665.84%	414.02%
Common Stock	$0.00	$0.00	$0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$8.476B	$5.547B	$5.197B
YoY Change
Total Liabilities & Shareholders Equity	$17.69B	$8.986B	$8.957B
YoY Change	96.9%	0.32%	0.18%

Cashflow Statement

Concept	2020 Q4	2019 Q4	2018 Q4
OPERATING ACTIVITIES
Net Income	-$322.8M	-$9.500M	$16.40M
YoY Change	3297.89%	-157.93%	-110.15%
Depreciation, Depletion And Amortization	$222.2M	$83.40M	$73.70M
YoY Change	166.43%	13.16%	-15.38%
Cash From Operating Activities	-$92.90M	$126.3M	$139.5M
YoY Change	-173.56%	-9.46%	1982.09%
INVESTING ACTIVITIES
Capital Expenditures	-$146.9M	-$111.4M	-$60.20M
YoY Change	31.87%	85.05%	-10.01%
Acquisitions
YoY Change
Other Investing Activities	$73.60M	$37.10M	$12.10M
YoY Change	98.38%	206.61%	-61.46%
Cash From Investing Activities	-$73.30M	-$74.30M	-$48.10M
YoY Change	-1.35%	54.47%	35.49%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-18.30M	-6.200M	-362.4M
YoY Change	195.16%	-98.29%	-9160.0%
NET CHANGE
Cash From Operating Activities	-92.90M	126.3M	139.5M
Cash From Investing Activities	-73.30M	-74.30M	-48.10M
Cash From Financing Activities	-18.30M	-6.200M	-362.4M
Net Change In Cash	-184.5M	45.80M	-271.0M
YoY Change	-502.84%	-116.9%	992.74%
FREE CASH FLOW
Cash From Operating Activities	-$92.90M	$126.3M	$139.5M
Capital Expenditures	-$146.9M	-$111.4M	-$60.20M
Free Cash Flow	$54.00M	$237.7M	$199.7M
YoY Change	-77.28%	19.03%	171.33%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2020	dei	Entity Central Index Key EntityCentralIndexKey	0001739104
CY2020	dei	Document Annual Report DocumentAnnualReport	true
CY2020	dei	Document Transition Report DocumentTransitionReport	false
CY2020	dei	Amendment Flag AmendmentFlag	false
CY2020	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2020
CY2020	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2020	us-gaap	Accounting Standards Update Extensible List AccountingStandardsUpdateExtensibleList	us-gaap:AccountingStandardsUpdate201613Member
CY2020Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	us-gaap:OtherLiabilitiesCurrent
CY2019Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	us-gaap:OtherLiabilitiesCurrent
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	us-gaap:OtherLiabilitiesNoncurrent
CY2019Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	us-gaap:OtherLiabilitiesNoncurrent
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P0Y
CY2020	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2020	dei	Document Type DocumentType	10-K
CY2020	dei	Document Period End Date DocumentPeriodEndDate	2020-12-31
CY2020	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2020	dei	Entity File Number EntityFileNumber	001-38661
CY2020	dei	Entity Registrant Name EntityRegistrantName	Elanco Animal Health Inc
CY2020	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	IN
CY2020	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	82-5497352
CY2020	dei	Entity Address Address Line1 EntityAddressAddressLine1	2500 INNOVATION WAY
CY2020	dei	Entity Address City Or Town EntityAddressCityOrTown	GREENFIELD
CY2020	dei	Entity Address State Or Province EntityAddressStateOrProvince	IN
CY2020	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	46140
CY2020	dei	City Area Code CityAreaCode	877
CY2020	dei	Local Phone Number LocalPhoneNumber	352-6261
CY2020	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2020	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2020	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2020	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2020	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2020	dei	Entity Small Business EntitySmallBusiness	false
CY2020	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2020	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2020	dei	Entity Shell Company EntityShellCompany	false
CY2020Q2	dei	Entity Public Float EntityPublicFloat	8600000000	USD
CY2021Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	472169683	shares
CY2020	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	3273300000	USD
CY2019	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	3071000000.0	USD
CY2018	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	3066800000	USD
CY2020	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1666600000	USD
CY2019	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1470300000	USD
CY2018	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1573800000	USD
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	327000000.0	USD
CY2019	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	270100000	USD
CY2018	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	246600000	USD
CY2020	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	996600000	USD
CY2019	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	760200000	USD
CY2018	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	735200000	USD
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	359900000	USD
CY2019	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	200400000	USD
CY2018	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	197400000	USD
CY2020	us-gaap	Restructuring Settlement And Impairment Provisions RestructuringSettlementAndImpairmentProvisions	623700000	USD
CY2019	us-gaap	Restructuring Settlement And Impairment Provisions RestructuringSettlementAndImpairmentProvisions	185500000	USD
CY2018	us-gaap	Restructuring Settlement And Impairment Provisions RestructuringSettlementAndImpairmentProvisions	128800000	USD
CY2020	us-gaap	Interest Expense InterestExpense	149800000	USD
CY2019	us-gaap	Interest Expense InterestExpense	78900000	USD
CY2018	us-gaap	Interest Expense InterestExpense	29600000	USD
CY2020	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	178300000	USD
CY2019	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-27400000	USD
CY2018	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-41300000	USD
CY2020	us-gaap	Costs And Expenses CostsAndExpenses	3945300000	USD
CY2019	us-gaap	Costs And Expenses CostsAndExpenses	2992800000	USD
CY2018	us-gaap	Costs And Expenses CostsAndExpenses	2952700000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-672000000.0	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	78200000	USD
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	114100000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-111900000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	10300000	USD
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	27600000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-560100000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	67900000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	86500000	USD
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.27
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.18
CY2018	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.28
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.27
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.18
CY2018	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.28
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	441400000	shares
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	369000000.0	shares
CY2018	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	313700000	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	441400000	shares
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	370300000	shares
CY2018	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	313700000	shares
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-560100000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	67900000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	86500000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax	-60400000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax	0	USD
CY2018	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax	0	USD
CY2020	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	558200000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	19800000	USD
CY2018	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-47100000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	21100000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-28700000	USD
CY2018	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-25400000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	476700000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	48500000	USD
CY2018	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-21700000	USD
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-83400000	USD
CY2019	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	116400000	USD
CY2018	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	64800000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	494700000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	334000000.0	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	8500000	USD
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	6200000	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	871600000	USD
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	816900000	USD
CY2020Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	205100000	USD
CY2019Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	73000000.0	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	1578100000	USD
CY2019Q4	us-gaap	Inventory Net InventoryNet	1050700000	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	256300000	USD
CY2019Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	87400000	USD
CY2020Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	10700000	USD
CY2019Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	11100000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	3416500000	USD
CY2019Q4	us-gaap	Assets Current AssetsCurrent	2373100000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	6224800000	USD
CY2019Q4	us-gaap	Goodwill Goodwill	2989600000	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	6387300000	USD
CY2019Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2482800000	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	347800000	USD
CY2019Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	185000000.0	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1316300000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	955300000	USD
CY2020Q4	us-gaap	Assets Assets	17692700000	USD
CY2019Q4	us-gaap	Assets Assets	8985800000	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	501000000.0	USD
CY2019Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	222600000	USD
CY2020Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	143600000	USD
CY2019Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	99600000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	295300000	USD
CY2019Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	211000000.0	USD
CY2020Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	554500000	USD
CY2019Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	24500000	USD
CY2020Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	576900000	USD
CY2019Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	244400000	USD
CY2020Q4	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	5000000.0	USD
CY2019Q4	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	16400000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2076300000	USD
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	818500000	USD
CY2020Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	5572400000	USD
CY2019Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	2330500000	USD
CY2020Q4	us-gaap	Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent	345700000	USD
CY2019Q4	us-gaap	Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent	82500000	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	900300000	USD
CY2019Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	100800000	USD
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	322100000	USD
CY2019Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	106600000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	9216800000	USD
CY2019Q4	us-gaap	Liabilities Liabilities	3438900000	USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000000	shares
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000000	shares
CY2019Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2020Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2020Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2019Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	5000000000	shares
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	5000000000	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	471921116	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	471921116	shares
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	373011513	shares
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	373011513	shares
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	0	USD
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	0	USD
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	8650100000	USD
CY2019Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	5636300000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-477200000	USD
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	84300000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	303000000.0	USD
CY2019Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-173700000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	8475900000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	5546900000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	17692700000	USD
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	8985800000	USD
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	7780300000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	86500000	USD
CY2018	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-21700000	USD
CY2018	elan	Stockholders Equity Transfers To From Parent StockholdersEquityTransfersToFromParent	-226300000	USD
CY2018	elan	Stockholders Equity Separation Adjustments StockholdersEquitySeparationAdjustments	99600000	USD
CY2018	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1659700000	USD
CY2018	elan	Stockholders Equity Consideration To Parent In Separation StockholdersEquityConsiderationToParentInSeparation	-4194900000	USD
CY2018	us-gaap	Reclassification From Aoci Current Period Net Of Tax Attributable To Parent ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent	0	USD
CY2018	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1800000	USD
CY2018	elan	Stockholders Equity Capital Contribution From Parent StockholdersEquityCapitalContributionFromParent	12800000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	5197500000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	67900000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	48500000	USD
CY2019	elan	Stockholders Equity Separation Adjustments StockholdersEquitySeparationAdjustments	-51200000	USD
CY2019	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	40700000	USD
CY2019	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	238000000.0	USD
CY2019	elan	Apic Share Based Payment Arrangement Increase For Cost Recognition Accelerated Vesting APICShareBasedPaymentArrangementIncreaseForCostRecognitionAcceleratedVesting	3600000	USD
CY2019	us-gaap	Stockholders Equity Other StockholdersEquityOther	-1900000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	5546900000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-560100000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	476700000	USD
CY2020	elan	Stockholders Equity Separation Adjustments StockholdersEquitySeparationAdjustments	38000000.0	USD
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	47700000	USD
CY2020	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	14400000	USD
CY2020	elan	Tangible Equity Units Issued During Period Value TangibleEquityUnitsIssuedDuringPeriodValue	1220000000.0	USD
CY2020	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	1722800000	USD
CY2020	us-gaap	Stockholders Equity Other StockholdersEquityOther	300000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	8475900000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-560100000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	67900000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	86500000	USD
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	516900000	USD
CY2019	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	314500000	USD
CY2018	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	296000000.0	USD
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-124800000	USD
CY2019	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	100000	USD
CY2018	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-60700000	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	47700000	USD
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	49400000	USD
CY2018	us-gaap	Share Based Compensation ShareBasedCompensation	26000000.0	USD
CY2020	elan	Asset Impairment Charges Including Inventory Write Down AssetImpairmentChargesIncludingInventoryWriteDown	25100000	USD
CY2019	elan	Asset Impairment Charges Including Inventory Write Down AssetImpairmentChargesIncludingInventoryWriteDown	32600000	USD
CY2018	elan	Asset Impairment Charges Including Inventory Write Down AssetImpairmentChargesIncludingInventoryWriteDown	120500000	USD
CY2020	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets	51300000	USD
CY2019	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets	0	USD
CY2018	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets	800000	USD
CY2020	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	170000000.0	USD
CY2019	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	0	USD
CY2018	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	0	USD
CY2020	elan	Inventory Fair Value Step Up Amortization InventoryFairValueStepUpAmortization	90100000	USD
CY2019	elan	Inventory Fair Value Step Up Amortization InventoryFairValueStepUpAmortization	600000	USD
CY2018	elan	Inventory Fair Value Step Up Amortization InventoryFairValueStepUpAmortization	0	USD
CY2020	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	19700000	USD
CY2019	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	-12700000	USD
CY2018	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	49000000.0	USD
CY2020	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	-14000000.0	USD
CY2019	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	172400000	USD
CY2018	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	122000000.0	USD
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	94700000	USD
CY2019	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	33700000	USD
CY2018	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	20100000	USD
CY2020	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	122900000	USD
CY2019	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-7000000.0	USD
CY2020	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	5001300000	USD
CY2020	elan	Proceeds From Payments To Transactions With Parent ProceedsFromPaymentsToTransactionsWithParent	0	USD
CY2019	elan	Proceeds From Payments To Transactions With Parent ProceedsFromPaymentsToTransactionsWithParent	6300000	USD
CY2018	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	3200000	USD
CY2020	us-gaap	Increase Decrease In Accounts Payable And Other Operating Liabilities IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities	369300000	USD
CY2019	us-gaap	Increase Decrease In Accounts Payable And Other Operating Liabilities IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities	-29200000	USD
CY2018	us-gaap	Increase Decrease In Accounts Payable And Other Operating Liabilities IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities	116100000	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-41000000.0	USD
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	224100000	USD
CY2018	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	487300000	USD
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	134600000	USD
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	140400000	USD
CY2018	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	134500000	USD
CY2020	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	72700000	USD
CY2019	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	300000	USD
CY2018	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	9400000	USD
CY2020	us-gaap	Payments To Acquire Software PaymentsToAcquireSoftware	176300000	USD
CY2019	us-gaap	Payments To Acquire Software PaymentsToAcquireSoftware	57000000.0	USD
CY2018	us-gaap	Payments To Acquire Software PaymentsToAcquireSoftware	2000000.0	USD
CY2019	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	32800000	USD
CY2018	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
CY2020	us-gaap	Proceeds From Divestiture Of Businesses And Interests In Affiliates ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates	434700000	USD
CY2019	us-gaap	Proceeds From Divestiture Of Businesses And Interests In Affiliates ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates	0	USD
CY2018	us-gaap	Proceeds From Divestiture Of Businesses And Interests In Affiliates ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates	0	USD
CY2020	us-gaap	Proceeds From Hedge Investing Activities ProceedsFromHedgeInvestingActivities	32700000	USD
CY2019	us-gaap	Proceeds From Hedge Investing Activities ProceedsFromHedgeInvestingActivities	0	USD
CY2018	us-gaap	Proceeds From Hedge Investing Activities ProceedsFromHedgeInvestingActivities	0	USD
CY2020	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	7100000	USD
CY2019	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	4900000	USD
CY2018	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-100000	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4779200000	USD
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-234800000	USD
CY2018	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-127000000.0	USD
CY2020	us-gaap	Proceeds From Issuance Of Senior Long Term Debt ProceedsFromIssuanceOfSeniorLongTermDebt	4804200000	USD
CY2019	us-gaap	Proceeds From Issuance Of Senior Long Term Debt ProceedsFromIssuanceOfSeniorLongTermDebt	0	USD
CY2018	us-gaap	Proceeds From Issuance Of Senior Long Term Debt ProceedsFromIssuanceOfSeniorLongTermDebt	2500000000.0	USD
CY2020	us-gaap	Repayments Of Senior Debt RepaymentsOfSeniorDebt	951500000	USD
CY2019	us-gaap	Repayments Of Senior Debt RepaymentsOfSeniorDebt	121100000	USD
CY2018	us-gaap	Repayments Of Senior Debt RepaymentsOfSeniorDebt	7500000	USD
CY2020	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1219900000	USD
CY2019	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2018	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1659700000	USD
CY2020	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	102500000	USD
CY2019	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
CY2018	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	24500000	USD
CY2020	elan	Payments Of Separation Related Costs Financing Activities PaymentsOfSeparationRelatedCostsFinancingActivities	0	USD
CY2019	elan	Payments Of Separation Related Costs Financing Activities PaymentsOfSeparationRelatedCostsFinancingActivities	191600000	USD
CY2018	elan	Payments Of Separation Related Costs Financing Activities PaymentsOfSeparationRelatedCostsFinancingActivities	3991300000	USD
CY2020	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-16200000	USD
CY2019	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	1600000	USD
CY2018	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-17200000	USD
CY2018	elan	Proceeds From Payments To Transactions With Parent ProceedsFromPaymentsToTransactionsWithParent	-154400000	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4953900000	USD
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-304800000	USD
CY2018	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-35200000	USD
CY2020	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	26600000	USD
CY2019	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-16900000	USD
CY2018	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	29000000.0	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	160300000	USD
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-332400000	USD
CY2018	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	354100000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	345100000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	677500000	USD
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	323400000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	505400000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	345100000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	677500000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	494700000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	334000000.0	USD
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	474800000	USD
CY2020Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	10700000	USD
CY2019Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	11100000	USD
CY2018Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	202700000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	505400000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	345100000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	677500000	USD
CY2020Q4	elan	Number Of Brands In Entitys Portfolio NumberOfBrandsInEntitysPortfolio	190	brand
CY2020Q4	us-gaap	Number Of Countries In Which Entity Operates NumberOfCountriesInWhichEntityOperates	90	country
CY2020	us-gaap	Basis Of Accounting BasisOfAccounting	Basis of Presentation <div style="margin-bottom:12pt;text-align:justify;text-indent:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have prepared the accompanying consolidated and combined financial statements in accordance with accounting principles generally accepted in the United States (GAAP). In our opinion, the financial statements reflect all adjustments (including those that are normal and recurring) that are necessary for fair presentation of the results of operations for the periods shown. The accounts of all wholly-owned and majority-owned subsidiaries are included in the consolidated and combined financial statements, and all intercompany balances and transactions have been eliminated. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In preparing financial statements in conformity with GAAP, we must make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, expenses, and related disclosures at the date of the financial statements and during the reporting period. Actual results could differ from those estimates. We issued our financial statements by filing with the Securities and Exchange Commission and have evaluated subsequent events up to the time of the filing. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the periods after Separation, the financial statements are prepared on a consolidated basis and reflect the results of operations, comprehensive income, financial position, equity and cash flows resulting from our operations as an independent company. For periods prior to Separation, our financial statements are combined, have been prepared on a standalone basis, and are derived from Lilly's consolidated financial statements and accounting records. The consolidated and combined financial statements reflect the financial position, results of operations and cash flows related to the animal health businesses that were transferred to Elanco Parent and are prepared in conformity with GAAP. </span></div><div style="text-align:justify;text-indent:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The combined financial statements include the attribution of certain assets and liabilities that historically have been held at the Lilly corporate level but which are specifically identifiable or attributable to the businesses that have been transferred to Elanco Parent. All intercompany transactions and accounts within Elanco have been eliminated. All transactions between us and Lilly are considered to be effectively settled in the combined financial statements at the time the intercompany transaction is recorded. The total net effect of the settlement of these intercompany transactions is reflected in the combined statements of cash flows as a financing activity and in the consolidated and combined statement of equity as net parent company investment.</span></div><div style="text-align:justify;text-indent:9pt"><span><br/></span></div><div style="text-align:justify;text-indent:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to Separation, these combined financial statements include an allocation of expenses related to certain Lilly corporate functions, including executive oversight, treasury, legal, finance, human resources, tax, internal audit, financial reporting, information technology and investor relations, prior to IPO. These expenses were allocated to us based on direct usage or benefit where specifically identifiable, with the remainder allocated primarily on a pro rata basis of revenue, headcount and other measures. We consider the expenses methodology and results to be reasonable; however, the allocations may not be indicative of the actual expense that would have been incurred had we operated as an independent, publicly traded company for the periods presented. It is impractical to estimate what the standalone costs of Elanco would have been in the historical periods. After the Separation, a TSA between Lilly and Elanco went into effect. Under the terms of the TSA, we will be able to use these Lilly services for a fixed term established on a service-by-service basis. We are paying Lilly mutually agreed upon fees for the Lilly services provided under the TSA. Our consolidated and combined financial statements reflect the charges for Lilly services after the IPO. See Note 21: Related Party Agreements and Transactions for additional details.</span></div><div style="text-indent:9pt"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to Separation, Lilly maintained various benefit and combined stock-based compensation plans at a corporate level and other benefit plans at a country level. Our employees participated in such programs and the portion of the cost of those plans related to our employees is included in our financial statements. However, the consolidated balance sheets do not include any equity issued related to stock-based compensation plans or any net benefit plan obligations unless the benefit plan covers only our dedicated employees or where the legal obligation associated with the benefit plan transferred to Elanco. Upon Lilly's full divestiture of Elanco in March 2019, all Lilly share-based awards held by our employees were converted into awards that will be settled in Elanco shares.</span></div><div style="text-align:justify;text-indent:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to Separation, our equity balance represented the excess of total assets over liabilities, including intercompany balances between Elanco and Lilly (net parent company investment) and accumulated other comprehensive income (loss). Net parent company investment is primarily impacted by contributions from Lilly which are the result of treasury activities and net funding provided by or distributed to Lilly. See Note 21: Related Party Agreements and Transactions for further information.</span></div><div style="text-align:justify;text-indent:9pt"><span><br/></span></div><div style="text-align:justify;text-indent:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The basis of presentation for our income tax amounts is discussed in Note 16: Income Taxes.</span></div>
CY2018Q3	elan	Stockholders Equity Separation Adjustments StockholdersEquitySeparationAdjustments	99600000	USD
CY2020	elan	Contract With Customer Rebate Period ContractWithCustomerRebatePeriod	P6M
CY2019Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	175900000	USD
CY2018Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	138200000	USD
CY2020	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	389300000	USD
CY2019	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	373900000	USD
CY2020	elan	Contract With Customer Liability Increase From Cash Receipts ContractWithCustomerLiabilityIncreaseFromCashReceipts	401300000	USD
CY2019	elan	Contract With Customer Liability Increase From Cash Receipts ContractWithCustomerLiabilityIncreaseFromCashReceipts	336200000	USD
CY2020	us-gaap	Contract With Customer Liability Increase Decrease For Contract Acquired In Business Combination ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination	49600000	USD
CY2019	us-gaap	Contract With Customer Liability Increase Decrease For Contract Acquired In Business Combination ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination	0	USD
CY2020	elan	Contract With Customer Liability Foreign Currency Translation ContractWithCustomerLiabilityForeignCurrencyTranslation	3000000.0	USD
CY2019	elan	Contract With Customer Liability Foreign Currency Translation ContractWithCustomerLiabilityForeignCurrencyTranslation	0	USD
CY2020Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	216500000	USD
CY2019Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	175900000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3273300000	USD
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3071000000.0	USD
CY2018	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3066800000	USD
CY2020Q3	elan	Payments To Acquire Businesses Before Working Capital Adjustment PaymentsToAcquireBusinessesBeforeWorkingCapitalAdjustment	5170100000	USD
CY2020Q3	elan	Business Combination Consideration Transferred Working Capital Adjustments BusinessCombinationConsiderationTransferredWorkingCapitalAdjustments	106800000	USD
CY2020	us-gaap	Severance Costs1 SeveranceCosts1	155000000.0	USD
CY2019	us-gaap	Severance Costs1 SeveranceCosts1	8200000	USD
CY2018	us-gaap	Severance Costs1 SeveranceCosts1	15500000	USD
CY2020	us-gaap	Business Exit Costs1 BusinessExitCosts1	-2700000	USD
CY2019	us-gaap	Business Exit Costs1 BusinessExitCosts1	0	USD
CY2018	us-gaap	Business Exit Costs1 BusinessExitCosts1	5700000	USD
CY2020	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	423800000	USD
CY2019	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	144700000	USD
CY2018	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	26500000	USD
CY2020	us-gaap	Asset Impairment Charges AssetImpairmentCharges	17500000	USD
CY2019	us-gaap	Asset Impairment Charges AssetImpairmentCharges	15400000	USD
CY2018	us-gaap	Asset Impairment Charges AssetImpairmentCharges	81900000	USD
CY2020	us-gaap	Disposal Group Not Discontinued Operation Loss Gain On Write Down DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown	19100000	USD
CY2019	us-gaap	Disposal Group Not Discontinued Operation Loss Gain On Write Down DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown	17200000	USD
CY2018	us-gaap	Disposal Group Not Discontinued Operation Loss Gain On Write Down DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown	0	USD
CY2020	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	3800000	USD
CY2019	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	0	USD
CY2018	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	800000	USD
CY2020	elan	Restructuring Charges Settlements And Other RestructuringChargesSettlementsAndOther	14800000	USD
CY2019	elan	Restructuring Charges Settlements And Other RestructuringChargesSettlementsAndOther	0	USD
CY2018	elan	Restructuring Charges Settlements And Other RestructuringChargesSettlementsAndOther	0	USD
CY2020	us-gaap	Restructuring Settlement And Impairment Provisions RestructuringSettlementAndImpairmentProvisions	623700000	USD
CY2019	us-gaap	Restructuring Settlement And Impairment Provisions RestructuringSettlementAndImpairmentProvisions	185500000	USD
CY2018	us-gaap	Restructuring Settlement And Impairment Provisions RestructuringSettlementAndImpairmentProvisions	128800000	USD
CY2019Q4	us-gaap	Disposal Group Including Discontinued Operation Property Plant And Equipment DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment	11200000	USD
CY2018Q4	us-gaap	Restructuring Reserve RestructuringReserve	44400000	USD
CY2019	us-gaap	Restructuring Charges RestructuringCharges	19300000	USD
CY2019	us-gaap	Restructuring Reserve Accrual Adjustment1 RestructuringReserveAccrualAdjustment1	-11100000	USD
CY2019	us-gaap	Payments For Restructuring PaymentsForRestructuring	31700000	USD
CY2019Q4	us-gaap	Restructuring Reserve RestructuringReserve	20900000	USD
CY2020	us-gaap	Restructuring Charges RestructuringCharges	156500000	USD
CY2020	us-gaap	Restructuring Reserve Accrual Adjustment1 RestructuringReserveAccrualAdjustment1	-4200000	USD
CY2020	us-gaap	Payments For Restructuring PaymentsForRestructuring	43500000	USD
CY2020Q4	us-gaap	Restructuring Reserve RestructuringReserve	129700000	USD
CY2020Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	771400000	USD
CY2019Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	402900000	USD
CY2020Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	625200000	USD
CY2019Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	603200000	USD
CY2020Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	210200000	USD
CY2019Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	83900000	USD
CY2020Q4	us-gaap	Inventory Gross InventoryGross	1606800000	USD
CY2019Q4	us-gaap	Inventory Gross InventoryGross	1090000000.0	USD
CY2020Q4	us-gaap	Inventory Lifo Reserve InventoryLIFOReserve	28700000	USD
CY2019Q4	us-gaap	Inventory Lifo Reserve InventoryLIFOReserve	39300000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	1578100000	USD
CY2019Q4	us-gaap	Inventory Net InventoryNet	1050700000	USD
CY2020Q4	us-gaap	Lifo Inventory Amount LIFOInventoryAmount	233600000	USD
CY2019Q4	us-gaap	Lifo Inventory Amount LIFOInventoryAmount	197200000	USD
CY2018	us-gaap	Inventory Write Down InventoryWriteDown	38600000	USD
CY2020Q1	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	25000000.0	shares
CY2020Q1	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	767500000	USD
CY2020Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	97700000	USD
CY2019Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	16800000	USD
CY2020Q4	us-gaap	Long Term Debt LongTermDebt	6126900000	USD
CY2019Q4	us-gaap	Long Term Debt LongTermDebt	2355000000.0	USD
CY2020Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	554500000	USD
CY2019Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	24500000	USD
CY2020Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	5572400000	USD
CY2019Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	2330500000	USD
CY2020Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	568900000	USD
CY2020Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	69600000	USD
CY2020Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	799600000	USD
CY2020Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	42800000	USD
CY2020Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	39900000	USD
CY2020Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	4703300000	USD
CY2020Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	6224100000	USD
CY2020Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	97200000	USD
CY2020Q4	us-gaap	Long Term Debt LongTermDebt	6126900000	USD
CY2020Q4	us-gaap	Deferred Finance Costs Gross DeferredFinanceCostsGross	90200000	USD
CY2020Q3	us-gaap	Debt Instrument Unused Borrowing Capacity Fee DebtInstrumentUnusedBorrowingCapacityFee	13800000	USD
CY2020Q4	us-gaap	Equity Method Investments EquityMethodInvestments	33400000	USD
CY2019Q4	us-gaap	Equity Method Investments EquityMethodInvestments	18800000	USD
CY2020	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	11000000.0	USD
CY2020Q4	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	-60400000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax	-15400000	USD
CY2020Q4	us-gaap	Interest Rate Cash Flow Hedge Gain Loss To Be Reclassified During Next12 Months Net InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet	-28500000	USD
CY2020	us-gaap	Interest Rate Cash Flow Hedge Gain Loss Reclassified To Earnings Net InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet	-7000000.0	USD
CY2020Q4	us-gaap	Goodwill Goodwill	6200000000	USD
CY2019Q4	us-gaap	Goodwill Goodwill	3000000000.0	USD
CY2019Q4	us-gaap	Goodwill Goodwill	2989600000	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	6387300000	USD
CY2020	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	19900000	USD
CY2020	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	2921600000	USD
CY2020	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	293700000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	6224800000	USD
CY2019	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2018	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2020	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	7801800000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1489500000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	6312300000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	3520200000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1086800000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2433400000	USD
CY2020Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	7876800000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1489500000	USD
CY2019Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	3569600000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1086800000	USD
CY2019Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2482800000	USD
CY2020	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	17500000	USD
CY2019	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	11400000	USD
CY2018	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	22500000	USD
CY2018	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	9500000	USD
CY2018	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	13000000.0	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	586500000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	585800000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	585500000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	581000000.0	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	563200000	USD
CY2020Q4	us-gaap	Finance Lease Right Of Use Asset Before Accumulated Amortization FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization	600000	USD
CY2019Q4	us-gaap	Finance Lease Right Of Use Asset Before Accumulated Amortization FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization	500000	USD
CY2020Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	2354200000	USD
CY2019Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	1885800000	USD
CY2020Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	1037900000	USD
CY2019Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	930500000	USD
CY2020Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	1316300000	USD
CY2019Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	955300000	USD
CY2020	us-gaap	Depreciation Depreciation	122000000.0	USD
CY2019	us-gaap	Depreciation Depreciation	93700000	USD
CY2018	us-gaap	Depreciation Depreciation	81300000	USD
CY2020	us-gaap	Operating Lease Cost OperatingLeaseCost	38400000	USD
CY2019	us-gaap	Operating Lease Cost OperatingLeaseCost	26100000	USD
CY2020	us-gaap	Short Term Lease Cost ShortTermLeaseCost	1200000	USD
CY2019	us-gaap	Short Term Lease Cost ShortTermLeaseCost	500000	USD
CY2020	us-gaap	Variable Lease Cost VariableLeaseCost	2800000	USD
CY2019	us-gaap	Variable Lease Cost VariableLeaseCost	2500000	USD
CY2020	us-gaap	Lease Cost LeaseCost	42400000	USD
CY2019	us-gaap	Lease Cost LeaseCost	29100000	USD
CY2020	us-gaap	Operating Lease Payments OperatingLeasePayments	35900000	USD
CY2019	us-gaap	Operating Lease Payments OperatingLeasePayments	24000000.0	USD
CY2020	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	138200000	USD
CY2019	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	20100000	USD
CY2020Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P8Y2M12D
CY2019Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y1M6D
CY2020Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.038
CY2019Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.036
CY2018	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	47500000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	187100000	USD
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	85000000.0	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	37000000.0	USD
CY2019Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	23700000	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	151400000	USD
CY2019Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	61700000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	43500000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	35600000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	26500000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	18900000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	16700000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	83400000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	224600000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	36200000	USD
CY2020Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	188400000	USD
CY2020Q2	elan	Sale Leaseback Transaction Net Proceeds SaleLeasebackTransactionNetProceeds	55100000	USD
CY2020Q2	us-gaap	Lessor Sales Type Lease Term Of Contract1 LessorSalesTypeLeaseTermOfContract1	P15Y
CY2020	us-gaap	Sale And Leaseback Transaction Gain Loss Net SaleAndLeasebackTransactionGainLossNet	45600000	USD
CY2020	us-gaap	Operating Lease Lease Income Lease Payments OperatingLeaseLeaseIncomeLeasePayments	27800000	USD
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	300000	shares
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	31.61
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2020	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	0	shares
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	0
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	300000	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	31.61
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y9M18D
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	USD
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	0	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0
CY2020Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	0	USD
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	10.21
CY2019Q4	elan	Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Weighted Average Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageIntrinsicValue	100000
CY2018Q4	elan	Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Weighted Average Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageIntrinsicValue	0
CY2019	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1900000	USD
CY2018	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-495000000.0	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	55500000	USD
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	12200000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-177000000.0	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	22700000	USD
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	101900000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-672000000.0	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	78200000	USD
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	114100000	USD
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-36000000.0	USD
CY2019	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-5500000	USD
CY2018	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	45100000	USD
CY2020	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	55600000	USD
CY2019	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	13400000	USD
CY2018	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	45500000	USD
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	-6700000	USD
CY2019	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	2300000	USD
CY2018	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	-2300000	USD
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	12900000	USD
CY2019	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	10200000	USD
CY2018	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	88300000	USD
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-8000000.0	USD
CY2019	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	14500000	USD
CY2018	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-56800000	USD
CY2020	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-124700000	USD
CY2019	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-7500000	USD
CY2018	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-5600000	USD
CY2020	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	7900000	USD
CY2019	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-6900000	USD
CY2018	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	1700000	USD
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-124800000	USD
CY2019	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	100000	USD
CY2018	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-60700000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-111900000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	10300000	USD
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	27600000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	68500000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	25300000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	88700000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	13700000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	33900000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	12800000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	168400000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	69500000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	18500000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	20100000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Restructuring Charges DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringCharges	32800000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Restructuring Charges DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringCharges	24600000	USD
CY2020Q4	elan	Deferred Tax Assets Operating Lease Right Of Use Liabilities DeferredTaxAssetsOperatingLeaseRightOfUseLiabilities	48400000	USD
CY2019Q4	elan	Deferred Tax Assets Operating Lease Right Of Use Liabilities DeferredTaxAssetsOperatingLeaseRightOfUseLiabilities	20500000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	24900000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	2300000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	484100000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	188800000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	94400000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	32700000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	389700000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	156100000	USD
CY2020Q4	elan	Deferred Tax Liabilities Operating Lease Right Of Use Assets DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets	48400000	USD
CY2019Q4	elan	Deferred Tax Liabilities Operating Lease Right Of Use Assets DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets	20500000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets	1043600000	USD
CY2019Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets	134500000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	114800000	USD
CY2019Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	56400000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	0	USD
CY2019Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	600000	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	1206800000	USD
CY2019Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	212000000.0	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	817100000	USD
CY2019Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	55900000	USD
CY2019Q4	us-gaap	Tax Credit Carryforward Amount TaxCreditCarryforwardAmount	33900000	USD
CY2020	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	97000000.0	USD
CY2019	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	42500000	USD
CY2018	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	26900000	USD
CY2020	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-141100000	USD
CY2019	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	16400000	USD
CY2018	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	24000000.0	USD
CY2020	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-14600000	USD
CY2019	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	20700000	USD
CY2018	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	20500000	USD
CY2020	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-10000000.0	USD
CY2019	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	2900000	USD
CY2018	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	4400000	USD
CY2020	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	23600000	USD
CY2019	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	9800000	USD
CY2018	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	17300000	USD
CY2020	elan	Effective Income Tax Rate Reconciliation Nondeductible Expense Employee Compensation EffectiveIncomeTaxRateReconciliationNondeductibleExpenseEmployeeCompensation	300000	USD
CY2019	elan	Effective Income Tax Rate Reconciliation Nondeductible Expense Employee Compensation EffectiveIncomeTaxRateReconciliationNondeductibleExpenseEmployeeCompensation	4200000	USD
CY2018	elan	Effective Income Tax Rate Reconciliation Nondeductible Expense Employee Compensation EffectiveIncomeTaxRateReconciliationNondeductibleExpenseEmployeeCompensation	-1900000	USD
CY2020	elan	Effective Income Tax Rate Reconciliation Nondeductible Expense Stock Issuance Costs EffectiveIncomeTaxRateReconciliationNondeductibleExpenseStockIssuanceCosts	0	USD
CY2019	elan	Effective Income Tax Rate Reconciliation Nondeductible Expense Stock Issuance Costs EffectiveIncomeTaxRateReconciliationNondeductibleExpenseStockIssuanceCosts	0	USD
CY2018	elan	Effective Income Tax Rate Reconciliation Nondeductible Expense Stock Issuance Costs EffectiveIncomeTaxRateReconciliationNondeductibleExpenseStockIssuanceCosts	2300000	USD
CY2020	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	17900000	USD
CY2019	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	-4200000	USD
CY2018	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	-1000000.0	USD
CY2020	us-gaap	Income Tax Reconciliation Tax Contingencies IncomeTaxReconciliationTaxContingencies	-7200000	USD
CY2019	us-gaap	Income Tax Reconciliation Tax Contingencies IncomeTaxReconciliationTaxContingencies	-14700000	USD
CY2018	us-gaap	Income Tax Reconciliation Tax Contingencies IncomeTaxReconciliationTaxContingencies	-1700000	USD
CY2020	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	66400000	USD
CY2019	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-5200000	USD
CY2018	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-1700000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-111900000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	10300000	USD
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	27600000	USD
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	8200000	USD
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	8200000	USD
CY2018Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	12500000	USD
CY2018	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	2200000	USD
CY2017Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	12000000.0	USD
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	100000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	1300000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	2100000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	1200000	USD
CY2018	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	4000000.0	USD
CY2020	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	3600000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	4300000	USD
CY2018	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	3000000.0	USD
CY2020	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Foreign Currency Translation UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation	100000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Foreign Currency Translation UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation	100000	USD
CY2018	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Foreign Currency Translation UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation	500000	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2500000	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	2500000	USD
CY2019Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	8200000	USD
CY2020	us-gaap	Income Tax Examination Penalties And Interest Expense IncomeTaxExaminationPenaltiesAndInterestExpense	-1700000	USD
CY2019	us-gaap	Income Tax Examination Penalties And Interest Expense IncomeTaxExaminationPenaltiesAndInterestExpense	-10600000	USD
CY2018	us-gaap	Income Tax Examination Penalties And Interest Expense IncomeTaxExaminationPenaltiesAndInterestExpense	-2500000	USD
CY2020Q4	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued	1300000	USD
CY2019Q4	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued	3000000.0	USD
CY2020Q4	elan	Loss Contingency Percent Of Te Us Issued Involved In Lawsuit LossContingencyPercentOfTEUsIssuedInvolvedInLawsuit	0.0500
CY2020	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	3273300000	USD
CY2019	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	3071000000.0	USD
CY2018	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	3066800000	USD
CY2020Q4	us-gaap	Noncurrent Assets NoncurrentAssets	1751300000	USD
CY2019Q4	us-gaap	Noncurrent Assets NoncurrentAssets	1147100000	USD
CY2019Q3	us-gaap	Defined Benefit Plan Plan Amendments DefinedBenefitPlanPlanAmendments	-21000000	USD
CY2019Q3	elan	Defined Benefit Plan Benefit Obligation Increase Decrease For Plan Amendment Prior Service Costs DefinedBenefitPlanBenefitObligationIncreaseDecreaseForPlanAmendmentPriorServiceCosts	-75000000	USD
CY2019Q3	elan	Defined Benefit Plan Benefit Obligation Increase Decrease For Plan Amendment Changes In Certain Assumptions DefinedBenefitPlanBenefitObligationIncreaseDecreaseForPlanAmendmentChangesInCertainAssumptions	-54000000	USD
CY2019Q3	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	-21000000	USD
CY2020Q4	us-gaap	Defined Benefit Plan Assumptions Used Calculating Benefit Obligation Rate Of Compensation Increase DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease	0.031
CY2019Q4	us-gaap	Defined Benefit Plan Assumptions Used Calculating Benefit Obligation Rate Of Compensation Increase DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease	0.023
CY2018Q4	us-gaap	Defined Benefit Plan Assumptions Used Calculating Benefit Obligation Rate Of Compensation Increase DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease	0.022
CY2020	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Rate Of Compensation Increase DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease	0.023
CY2019	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Rate Of Compensation Increase DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease	0.022
CY2020Q4	us-gaap	Defined Benefit Plan Expected Future Employer Contributions Next Fiscal Year DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear	18100000	USD
CY2018	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Rate Of Compensation Increase DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease	0.021
CY2020	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	35200000	USD
CY2018	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	20900000	USD
CY2019	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	32200000	USD
CY2020	us-gaap	Multiemployer Plan Employer Contribution Cost MultiemployerPlanEmployerContributionCost	1700000	USD
CY2018Q3	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	2932900
CY2019	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	1300000	shares
CY2019	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	100000	shares
CY2020Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	10700000	USD
CY2020Q4	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	1139700000	USD
CY2020Q4	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	596200000	USD
CY2020Q4	us-gaap	Operating Expenses OperatingExpenses	486800000	USD
CY2020Q4	us-gaap	Restructuring Settlement And Impairment Provisions RestructuringSettlementAndImpairmentProvisions	167300000	USD
CY2020Q4	us-gaap	Interest Expense InterestExpense	60400000	USD
CY2020Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-318100000	USD
CY2020Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4700000	USD
CY2020Q4	us-gaap	Net Income Loss NetIncomeLoss	-322800000	USD
CY2020Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.66
CY2019Q4	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	787000000.0	USD
CY2019Q4	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	410100000	USD
CY2019Q4	us-gaap	Operating Expenses OperatingExpenses	253200000	USD
CY2019Q4	us-gaap	Restructuring Settlement And Impairment Provisions RestructuringSettlementAndImpairmentProvisions	51600000	USD
CY2019Q4	us-gaap	Interest Expense InterestExpense	18700000	USD
CY2019Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4300000	USD
CY2019Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	5200000	USD
CY2019Q4	us-gaap	Net Income Loss NetIncomeLoss	-9500000	USD
CY2019Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.03

Files In Submission

Name	View Source	Status
0001739104-21-000004-index-headers.html	Edgar Link	pending
0001739104-21-000004-index.html	Edgar Link	pending
0001739104-21-000004.txt	Edgar Link	pending
0001739104-21-000004-xbrl.zip	Edgar Link	pending
elan-20201231.htm	Edgar Link	pending
elan-20201231.xsd	Edgar Link	pending
elan-20201231_cal.xml	Edgar Link	unprocessable
elan-20201231_def.xml	Edgar Link	unprocessable
elan-20201231_g1.jpg	Edgar Link	pending
elan-20201231_g2.jpg	Edgar Link	pending
elan-20201231_g3.jpg	Edgar Link	pending
elan-20201231_g4.jpg	Edgar Link	pending
elan-20201231_g5.jpg	Edgar Link	pending
elan-20201231_htm.xml	Edgar Link	completed
elan-20201231_lab.xml	Edgar Link	unprocessable
elan-20201231_pre.xml	Edgar Link	unprocessable
ex1031elancoexecutivenon-c.htm	Edgar Link	pending
ex211elanco-20201231subsid.htm	Edgar Link	pending
ex231elanco-20201231xeycon.htm	Edgar Link	pending
ex311elanco-20201231certif.htm	Edgar Link	pending
ex312elanco-20201231certif.htm	Edgar Link	pending
ex32elanco-20201231x1350ce.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R106.htm	Edgar Link	pending
R107.htm	Edgar Link	pending
R108.htm	Edgar Link	pending
R109.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R110.htm	Edgar Link	pending
R111.htm	Edgar Link	pending
R112.htm	Edgar Link	pending
R113.htm	Edgar Link	pending
R114.htm	Edgar Link	pending
R115.htm	Edgar Link	pending
R116.htm	Edgar Link	pending
R117.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ELAN
Elanco Animal Health Inc Stock $elan

2020 Q4 Form 10-K Financial Statement

#000173910421000004 Filed on March 01, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ELAN Elanco Animal Health Inc Stock $elan

2020 Q4 Form 10-K Financial Statement

#000173910421000004 Filed on March 01, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ELAN
Elanco Animal Health Inc Stock $elan